Advances in Therapy View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1984

PUBLISHER

Springer Healthcare

LANGUAGE

en

HOMEPAGE

https://link.springer.com/journal/12325

Recent publications latest 20 shown

  • 2022-11-18 Correction to: Identifying Patients for Self-Administration of Omalizumab
  • 2022-11-18 Direct Oral Anticoagulant (DOAC) Dosing in Patients with Non-valvular Atrial Fibrillation (NVAF) in the United Kingdom: A Retrospective Cohort Study Using CPRD Gold Database
  • 2022-11-18 Efficacy and Safety of PD-1/PD-L1 Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
  • 2022-11-09 Adverse Events Reported with Therapies Targeting the CGRP Pathway During the First 6 Months Post-launch: A Retrospective Analysis Using the FDA Adverse Events Reporting System
  • 2022-11-08 Safety of SABA Monotherapy in Asthma Management: a Systematic Review and Meta-analysis
  • 2022-11-08 Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation
  • 2022-11-04 Recurrence Rates and Pharmacological Treatment for Hemorrhoidal Disease: A Systematic Review
  • 2022-11-01 No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab
  • 2022-11-01 Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer
  • 2022-11-01 Advances in Delivery of Selective Internal Radiation Therapy (SIRT): Economic and Logistical Effects of Same-Stay Work-Up and Procedure in the Treatment of Unresectable Liver Tumors in England
  • 2022-10-31 Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting
  • 2022-10-31 Correction to: Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
  • 2022-10-31 Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries
  • 2022-10-29 Examining the Systemic Bioavailability of Cannabidiol and Tetrahydrocannabinol from a Novel Transdermal Delivery System in Healthy Adults: A Single-Arm, Open-Label, Exploratory Study
  • 2022-10-28 Projecting the Epidemiological and Economic Impact of Chronic Kidney Disease Using Patient-Level Microsimulation Modelling: Rationale and Methods of Inside CKD
  • 2022-10-28 Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer in the United States, Europe, and Israel
  • 2022-10-28 Letter to the Editor Regarding Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM
  • 2022-10-27 A Two-Step, Trajectory-Focused, Analytics Approach to Attempt Prediction of Analgesic Response in Patients with Moderate-to-Severe Osteoarthritis
  • 2022-10-26 Peripheral Treg Levels and Transforming Growth Factor-β (TGFβ) in Patients with Psoriatic Arthritis: A Systematic Review Meta-Analysis
  • 2022-10-26 European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "1.3700000047683716", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "1.0299999713897705", 
            "type": "Rating"
          }
        ], 
        "description": "

    Advances in Therapy is an international, open choice, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, covering the use of therapies, devices, and surgical techniques across all therapy areas. The key features of the journal are:
    \nRapid publication: The journal aims for a 2-week peer review, 3-4 weeks from acceptance to online.
    \nInclusivity: All scientifically sound research considered be it positive, confirmatory or negative data. Research is considered from clinical phase, real-world and health economics outcomes studies. Submissions are welcomed whether they relate to an international or a country-specific audience.
    \nPersonal service: The journal’s team will re-format articles and upload submissions on behalf of authors, if necessary.
    \nDigital Features and Plain Language Summaries: These peer-reviewed features are welcomed to help enhance the educational value of a manuscript (for more information see “Author Information – Guidelines for digital features and plain language summaries” under “Submission guidelines”).
    \nPublication fees: Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €6250/ $7100 / £5100. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis.
    \nOpen access option: Advances in Therapy offers an open access option for all articles submitted to the journal. If you choose open access publication you will be required to pay a fee of €3190/ $4190/ £2690 (in addition to the mandatory Rapid Service Fee), upon acceptance of your article.
    \nContact: For more information about the journal, including pre-submission enquiries, please contact Lucy Holt at lucy.holt@springer.com.  

    \n", "id": "sg:journal.1096634", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "0741-238X", "1865-8652" ], "license": "Hybrid", "name": "Advances in Therapy", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "96634" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "sn 83003198" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "8611864" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "437393" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "36341" ] } ], "publisher": { "name": "Springer Healthcare", "type": "Organization" }, "publisherImprint": "Adis", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1096634" ], "sdDataset": "journals", "sdDatePublished": "2022-11-24T21:22", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/journal/journal_0.jsonl", "startYear": "1984", "type": "Periodical", "url": "https://link.springer.com/journal/12325" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1096634'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1096634'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1096634'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1096634'


     

    This table displays all metadata directly associated to this object as RDF triples.

    54 TRIPLES      19 PREDICATES      26 URIs      22 LITERALS      9 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1096634 schema:contentRating N14d8ea4ea4864aeb8bd04d2b9f82b937
    2 Nf79c3a51bec84f0191cec34a93a03877
    3 schema:description <p><em>Advances in&nbsp;Therapy</em> is an international, open choice, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, covering the use of therapies, devices, and surgical techniques across all therapy areas. The key features of the journal are:<br /> <strong>Rapid publication</strong>: The journal aims for a 2-week peer review, 3-4 weeks from acceptance to online.<br /> <strong>Inclusivity:</strong> All scientifically sound research considered be it positive, confirmatory or negative data. Research is considered from clinical phase, real-world and health economics outcomes studies. Submissions are welcomed whether they relate to an international or a country-specific audience.<br /> <strong>Personal service</strong>: The journal&rsquo;s team will re-format articles and upload submissions on behalf of authors, if necessary.<br /> <strong>Digital Features and Plain Language Summaries: </strong>These peer-reviewed features are welcomed to help enhance the educational value of a manuscript (for more information see &ldquo;Author Information &ndash; Guidelines for digital features and plain language summaries&rdquo; under &ldquo;Submission guidelines&rdquo;).<br /> <strong>Publication fees</strong>: Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of &euro;6250/ $7100 / &pound;5100. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis.<br /> <strong>Open access option:&nbsp;</strong><em>Advances in Therapy</em> offers an open access option for all articles submitted to the journal. If you choose open access publication you will be required to pay a fee of &euro;3190/ $4190/ &pound;2690 (in addition to the mandatory Rapid Service Fee), upon acceptance of your article.<br /> <strong>Contact:&nbsp;</strong>For more information about the journal, including pre-submission enquiries, please contact Lucy Holt&nbsp;at lucy.holt@springer.com.&nbsp;&nbsp;</p>
    4 schema:inLanguage en
    5 schema:isAccessibleForFree false
    6 schema:issn 0741-238X
    7 1865-8652
    8 schema:license Hybrid
    9 schema:name Advances in Therapy
    10 schema:productId N200990d7d396414592c390db8e633c05
    11 N209b9bd3573c4368a59b327939f12700
    12 N7631b65feb7f40408e468b4be48ffdd7
    13 N99f6b2b5383443549d5c9be0819e9774
    14 Nedd9fac429974299897ebd99f2f71be0
    15 schema:publisher N773218b5d9dd43019db71c5e32c04832
    16 schema:publisherImprint Adis
    17 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1096634
    18 schema:sdDatePublished 2022-11-24T21:22
    19 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    20 schema:sdPublisher N4da970f385164ae7bab0d9f67a798626
    21 schema:startYear 1984
    22 schema:url https://link.springer.com/journal/12325
    23 sgo:license sg:explorer/license/
    24 sgo:sdDataset journals
    25 rdf:type schema:Periodical
    26 N14d8ea4ea4864aeb8bd04d2b9f82b937 schema:author N7037f919aaa84d3e88914edbffca0ed6
    27 schema:ratingValue 1.3700000047683716
    28 rdf:type schema:Rating
    29 N200990d7d396414592c390db8e633c05 schema:name dimensions_id
    30 schema:value 96634
    31 rdf:type schema:PropertyValue
    32 N209b9bd3573c4368a59b327939f12700 schema:name era_ids_id
    33 schema:value 36341
    34 rdf:type schema:PropertyValue
    35 N4da970f385164ae7bab0d9f67a798626 schema:name Springer Nature - SN SciGraph project
    36 rdf:type schema:Organization
    37 N7037f919aaa84d3e88914edbffca0ed6 rdf:first snip
    38 rdf:rest rdf:nil
    39 N7631b65feb7f40408e468b4be48ffdd7 schema:name nsd_ids_id
    40 schema:value 437393
    41 rdf:type schema:PropertyValue
    42 N773218b5d9dd43019db71c5e32c04832 schema:name Springer Healthcare
    43 rdf:type schema:Organization
    44 N99f6b2b5383443549d5c9be0819e9774 schema:name lccn_id
    45 schema:value sn 83003198
    46 rdf:type schema:PropertyValue
    47 Ne4f97236eb3f4abcb7313e31e0ddc649 rdf:first sjr
    48 rdf:rest rdf:nil
    49 Nedd9fac429974299897ebd99f2f71be0 schema:name nlm_unique_id
    50 schema:value 8611864
    51 rdf:type schema:PropertyValue
    52 Nf79c3a51bec84f0191cec34a93a03877 schema:author Ne4f97236eb3f4abcb7313e31e0ddc649
    53 schema:ratingValue 1.0299999713897705
    54 rdf:type schema:Rating
     




    Preview window. Press ESC to close (or click here)


    ...